If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInter. Pers. Regulatory News (IPF)

Share Price Information for Inter. Pers. (IPF)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 108.50
Bid: 108.00
Ask: 109.50
Change: -1.50 (-1.36%)
Spread: 1.50 (1.389%)
Open: 109.50
High: 109.50
Low: 108.00
Prev. Close: 110.00
IPF Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed revisions to draft TCC amendment law

13 Jul 2015 07:00

RNS Number : 8326S
International Personal Finance Plc
13 July 2015
 



 

13 July 2015

 

 

INTERNATIONAL PERSONAL FINANCE PLC ("IPF" or the "Company")

 

IPF NOTES RECENTLY PROPOSED REVISIONS TO DRAFT TOTAL COST OF CREDIT AMENDMENT LAW IN POLAND

 

 

In August 2013, the Ministry of Finance in Poland issued draft proposals containing amendments to Polish consumer finance law. The draft proposals and subsequent updates were adopted by the Government in May 2015 and included a cap on all mandatory, non-interest costs charged for a consumer loan as part of the total cost of credit.

 

As previously announced, IPF developed a product which addressed and complied with the draft legislation prepared by the Government.

 

Following an intervention by a Member of Parliament of the ruling party late in the process, on 10 July the Lower Chamber of the Polish Parliament voted in favour of revisions to the draft law that would cap all non-interest costs, whether mandatory or not. If the legislation is enacted as currently drafted, IPF believes that all non-interest costs in connection with a consumer loan agreement may be subject to the cap.

 

The level of the cap has not changed from the prior draft: (i) a flat level of 25% of the loan value; and (ii) an additional cap of 30% per annum. The combined total of the flat 25% and the time-dependent 30% p.a. may not, in any event, exceed 100% of the loan value. Pursuant to the current draft of the amendments, interest would continue to be capped at four times the Lombard Rate. In addition, a new cap on penalty interest (six times Lombard Rate) and restrictions on additional loans entered into within a period of 120 days of an existing loan would apply.

 

IPF is reviewing the draft legislation to assess whether its product structure will be affected by the proposed cap. In addition, we are proactively developing an alternative product structure to mitigate any adverse financial impact to the greatest extent possible. Dependent on legal interpretation of the final version, however, there can be no assurance that the legislation, if introduced in its present form, would not have some adverse financial impact on IPF.

 

The draft law will now go to the Upper Chamber of Parliament, where it can be accepted, amended or recommended for withdrawal. If the Upper Chamber supports the draft legislation it will go to the President, who then has 21 days to sign the legislation into law, withdraw or send it to the Supreme Court. According to the current draft of the legislation, it would become effective and lenders would be required to comply from six months after signature by the President.

 

IPF will keep the market updated and further details will be communicated in due course. IPF will be reporting its interim results for the six months ending 30 June 2015 on Wednesday 29 July 2015.

 

International Personal Finance will host a conference call for investors and analysts at 07:45hrs (BST) today, Monday 13 July.

Dial-in (UK)

+44 (0) 20 8150 0794

Dial-in (US)

877-857-6151

Confirmation code

2621778

 

An audio recording will be available at www.ipfin.co.uk/investors from 14 July 2015.

 

Investor relations and media contacts:

International Personal Finance

Rachel Moran - Investor Relations

+44 (0)7760 167637 / +44 (0)113 285 6798

Gergely Mikola - Media

(+3620) 339 02 25

 

FTI Consulting

Neil Doyle

+44 20 3727 1141 / +44 7771 978 220

Paul Marriott

+44 20 3727 1341 / +44 7710 426 131

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFESIDFISEEW
Date   Source Headline
2nd May 20241:53 pmRNSResults of AGM
2nd May 20247:00 amRNSQ1 2024 Trading Update
1st May 20246:01 pmRNSBoard Committee Membership Changes
1st May 20246:00 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
8th Apr 20241:13 pmRNSDirector/PDMR Shareholding
5th Apr 202410:00 amRNSDirector/PDMR Shareholding
4th Apr 202410:48 amRNSDirector/PDMR Shareholding
3rd Apr 20243:29 pmRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
27th Mar 20245:09 pmRNSDirector/PDMR Shareholding
25th Mar 20244:44 pmRNSAnnual Financial Report and Notice of AGM
21st Mar 20245:09 pmRNSDirector/PDMR Shareholding
19th Mar 20243:56 pmRNSDirector/PDMR Shareholding
18th Mar 20244:11 pmRNSDirector/PDMR Shareholding
15th Mar 202410:38 amRNSFinal Dividend Timetable Correction
14th Mar 20247:00 amRNSFinal Results and Accounts
26th Feb 20247:00 amRNSDelay of year-end results announcement
8th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Dec 20239:08 amRNSHolding(s) in Company
14th Dec 202311:24 amRNSPublication of Final Terms
24th Nov 20237:02 amRNSDirector/PDMR Shareholding
24th Nov 20237:00 amRNSFinal Confirmation & Results of Exchange Offer
17th Nov 20233:18 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSAppointment of Joint Broker
14th Nov 20233:09 pmRNSHolding(s) in Company
8th Nov 20237:00 amRNSNotice of Investor Webinar - 7 December 2023
3rd Nov 20234:14 pmRNSIssuance and amendment to Final Terms
2nd Nov 20231:29 pmRNSCash Offer Launch
2nd Nov 20231:18 pmRNSExchange Offer
2nd Nov 20231:16 pmRNSPublication of a Prospectus
26th Oct 20237:01 amRNSRoadshow Announcement
26th Oct 20237:00 amRNSQ3 2023 Trading Update
25th Oct 20232:12 pmRNSChange of Senior Independent Director
24th Oct 20233:19 pmRNSPublication of Final Terms - Replacement Notice
24th Oct 20237:00 amRNSPublication of Final Terms
20th Oct 20237:00 amRNSUpdate on Annual General Meeting 2023 Vote
2nd Oct 20237:00 amRNSTotal Voting Rights
14th Sep 20231:46 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSTotal Voting Rights
24th Aug 20234:35 pmRNSPublication of a Prospectus
1st Aug 20237:00 amRNSHalf-year Report
13th Jul 202311:14 amRNSHolding(s) in Company
3rd Jul 20232:30 pmRNSTotal Voting Rights
3rd Jul 20239:20 amRNSBlock listing Interim Review
1st Jun 20237:00 amRNSTotal Voting Rights
11th May 20234:48 pmRNSDirector/PDMR Shareholding
4th May 202311:17 amRNSDirector/PDMR Shareholding
2nd May 202312:28 pmRNSTotal Voting Rights
27th Apr 20234:27 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.